What to Consider When Choosing a GLP-1 Provider Rachel Pessah-Pollack, MD, a diabetes and metabolism endocrinologist in New Hyde Park, New York, recommends finding a provider who is board-certified and has expertise in weight management, endocrinology, and metabolism
Recent studies indicate that both semaglutide and tirzepatide are priced excessively high, requiring significant reductions to be deemed cost-effective
There is no single number that applies to everyone, and no one should treat nuts as a dose
Sorry, there was an error processing your request
revealed that while transient skin-benefitting results were seen in 37.5% of patients with IV glutathione (1200 mg twice weekly for six weeks), 32% developed adverse events, again revealing a large risk-to-benefit ratio imbalance
Hepatic impairment Mild to moderate hepatic impairment does not require dose adjustments